Dogwood Therapeutics (DWTX) Prepaid Assets (2020 - 2026)
Dogwood Therapeutics (DWTX) posted quarterly Prepaid Assets of $1.8 million for Q1 2026, up 9.33% year-over-year from $1.6 million in Q1 2025, and up 246.58% quarter-over-quarter from $512523.0 in Q4 2025.
Dogwood Therapeutics (DWTX) Prepaid Assets (2020 - 2026) Analysis & Trends
Dogwood Therapeutics (DWTX) has reported Prepaid Assets for 7 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 9.33% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 9.33% YoY), while the FY2025 annual figure was $512523.0, down 23.19% from the prior year.
- Prepaid Assets improved to $1.8 million in Q1 2026 per DWTX's latest filing, from $512523.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.8 million in Q1 2026 and bottomed at $171708.0 in Q3 2024.
- Historically, Prepaid Assets has averaged $800819.9 across 5 years, with a median of $663921.0 in 2022.
- Annual changes were most pronounced in 2022 — Prepaid Assets sank 72.6% — and 2025, when it soared 790.27%.
- Dogwood Therapeutics' Prepaid Assets stood at $1.3 million in 2022, then sank by 36.62% to $848496.0 in 2023, then declined by 21.36% to $667257.0 in 2024, then slipped by 23.19% to $512523.0 in 2025, then jumped by 246.58% to $1.8 million in 2026.
- Business Quant data shows DWTX's Prepaid Assets at $1.8 million in Q1 2026, $512523.0 in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dogwood Therapeutics | 84.98 Mn | 84.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 512,523.00 |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 347,811.00 |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 667,257.00 |
| Sep 30, 2024 | 171,708.00 |
| Jun 30, 2024 | 352,204.00 |
| Mar 31, 2024 | 533,754.00 |
| Dec 31, 2023 | 848,496.00 |
| Sep 30, 2023 | 462,788.00 |
| Jun 30, 2023 | 576,668.00 |
| Mar 31, 2023 | 878,702.00 |
| Dec 31, 2022 | 1.34 Mn |
| Sep 30, 2022 | 318,901.00 |
| Jun 30, 2022 | 663,921.00 |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 1.77 Mn |
| Sep 30, 2021 | 383,569.00 |
| Jun 30, 2021 | 807,133.00 |